Onkološki inštitut Ljubljana (OILJ)
  • Intermittent chemotherapy and erlotinib for advanced NSCLC with EGFR activating mutations
    Zwitter, Matjaž ...
    Vir: Journal of thoracic oncology. - ISSN 1556-0864 (Vol. 7, no. 9, suppl. 4, Sep. 2012, str. S216)
    Vrsta gradiva - prispevek na konferenci ; neleposlovje za odrasle
    Leto - 2012
    Jezik - angleški
    COBISS.SI-ID - 1345147

vir: Journal of thoracic oncology. - ISSN 1556-0864 (Vol. 7, no. 9, suppl. 4, Sep. 2012, str. S216)

loading ...
loading ...
loading ...